The hypothesis put forth in this application is that HLA-D region gene products function in the regulation of proliferation within the hematopoietic system. Recent observations in support of this theory have suggested the following: 1) Three is HLA-DR-restricted cooperation between T cells and monocytes that regulates the production of erythroid burst (BFU-E)-stimulating activities; 2) immature hematopoietic precursors like the BFU-E express HLA-DR molecules; and 3) HLA-DR antigens expressed on myeloid cells (i.e. BFU-E, CFU-GM, monocytes) differ from DR antigens expressed on lymphocytes from the same individual. Taken together, these data suggest that HLA-D region-encoded molecules may provide the basis for tissue-specific recognition signals, allowing for selective compartmentalization and regulation of DR-associated function. Proof of this theory requires demonstrating cell-cell interactions or cell-factor interactions that are facilitated and genetically limited by these molecules.
One specific aim directed at this goal involves identifying the basis of the molecular variation in DR molecules expressed by myeloid cells as compared to lymphoid cells. The proposed biochemical analysis of these variants will be greatly facilitated by the recent development of a DR-positive erythroid leukemia cell line and an autologous DR-positive B-lymphoblastoid line. These lines will also be used to generate new monoclonal antibodies that will distinguish between DR molecules. Newly developed monoclonal antibodies will then be used to study the structure of DR molecules expressed on normal hematopoietic precursors and to improve techniques for isolating highly enriched populations of these cells. Enriched populations of precursor cells will be used to study genetically restricted cell-cell and cell-factor interactions that regulate in vitro hematopoiesis. Identifying a regulatory system facilitated and genetically restricted by D-region gene products may provide new insights for studying dysplasias associated with autoimmune phenomenon as well as contribute to our understanding of the regulation of normal hematopoiesis.
|Iwata, M; Vieira, J; Byrne, M et al. (1999) Interleukin-1 (IL-1) inhibits growth of cytomegalovirus in human marrow stromal cells: inhibition is reversed upon removal of IL-1. Blood 94:572-8|
|Torok-Storb, B; Iwata, M; Graf, L et al. (1999) Dissecting the marrow microenvironment. Ann N Y Acad Sci 872:164-70|
|Roecklein, B A; Reems, J; Rowley, S et al. (1998) Ex vivo expansion of immature 4-hydroperoxycyclophosphamide-resistant progenitor cells from G-CSF-mobilized peripheral blood. Biol Blood Marrow Transplant 4:61-8|
|Li, L; Milner, L A; Deng, Y et al. (1998) The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1. Immunity 8:43-55|
|Boeckh, M; Hoy, C; Torok-Storb, B (1998) Occult cytomegalovirus infection of marrow stroma. Clin Infect Dis 26:209-10|
|Reems, J A; Mielcarek, M; Torok-Storb, B (1997) Differential modulation of adhesion markers with ex vivo expansion of human umbilical CD34+ progenitor cells. Biol Blood Marrow Transplant 3:133-41|
|Mielcarek, M; Reems, J; Torok-Storb, B (1997) Extrinsic control of stem cell fate: practical considerations. Stem Cells 15 Suppl 1:229-32; discussion 233-6|
|Mielcarek, M; Martin, P J; Torok-Storb, B (1997) Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood 89:1629-34|
|Kirk, J A; Radich, J; Edmands, S et al. (1996) Unusual expression of mRNA typical of Philadelphia positive acute lymphoblastic leukemia detected in chronic myeloid leukemia. Am J Hematol 52:129-34|
|Mielcarek, M; Roecklein, B A; Torok-Storb, B (1996) CD14+ cells in granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood mononuclear cells induce secretion of interleukin-6 and G-CSF by marrow stroma. Blood 87:574-80|
Showing the most recent 10 out of 34 publications